Navigation Links
ProUroCare Medical Elects Larry W. Getlin as New Director
Date:7/7/2011

ional Society (RAPS).

About ProUroCare Medical Inc.

ProUroCare Medical Inc. is a publicly traded company engaged in the business of developing innovative medical imaging products.  The company's ProUroScan system, an elasticity imaging technology used to document abnormalities of the prostate previously detected by a digital rectal examination, is currently under review by the FDA for commercial clearance.

Safe Harbor Statement

This news release contains certain "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded by words such as "believes," "expects," "anticipates," "intends," "will," "may," "should," or similar expressions. These forward-looking statements are not guarantees of ProUroCare's future performance and involve a number of risks and uncertainties that may cause actual results to differ materially from the results discussed in these statements.  Factors that might cause ProUroCare's results to differ materially from those expressed or implied by such forward looking statements include, but are not limited to, the ability of ProUroCare to find adequate financing to complete the development of its products; the high level of secured and unsecured debt incurred by ProUroCare; the impact and timing of actions taken by the FDA and other regulatory agencies with respect to ProUroCare's products and business;  the dependence by ProUroCare on third parties for the development and manufacture of its products; and other risks and uncertainties detailed from time to time in ProUroCare's filings with the Securities and Exchange Commission including its most recently filed Form 10-K and Form 10-Q. ProUroCare undertakes no duty to update any of these forward-looking statements.


'/>"/>
SOURCE ProUroCare Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ProUroCare Medical Inc. Announces Pricing of Equity Offering
2. ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology
3. ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities
4. ProUroCare Medical Elects Two New Directors
5. ProUroCare Medical Announces Filing of Request to Classify the Prostate Mechanical Imager ("PMI") as a Class II Device
6. ProUroCare to Showcase Investigational Portable Platform for Its Prostate Imaging Device at AUA 2010
7. ProUroCare Medical Secures $885,000 in Financing
8. ProUroCare Medical Announces Offering of Replacement Warrants in Exchange for Early Exercise of Outstanding Warrants
9. ProUroCare Medical Inc. Announces Completion of Warrant Replacement Offering
10. UPDATE - ProUroCare Announces $3 Million Financing Agreement
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015 WuXi PharmaTech (Cayman) Inc. ... platform company serving the pharmaceutical, biotechnology, and medical device ... and the United States , congratulates ... from the U.S. FDA for ibalizumab (TMB355). The FDA ... is intended, alone or in combination with one or ...
(Date:2/27/2015)...  Following a bipartisan vote in the House ... the Medicare DMEPOS Competitive Bidding Improvement Act of ... released a statement praising the Committee,s work and ... "Today,s mark-up of the Competitive Bidding ... Committee is a critical step forward for this ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 /PRNewswire/ - ESSA ... Bloom Burton & Co. Ltd. ("Bloom Burton") today announced ... "Lock-Up") 2,353,130 common shares of the Company ("Common Shares") ... the Lock-Up. Of the Common Shares released from the ... release from the Lock-Up while the remainder will be ...
Breaking Medicine Technology:WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA 2Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4
(Date:3/1/2015)... 2015 A federal court overseeing ... scheduled to go to trial in October has ... to provide testimony regarding the role an Italian ... Profemur device, Bernstein Liebhard LLP comments. According to ... District of Iowa on February 25th, Wright Medical ...
(Date:3/1/2015)... 01, 2015 The number of transvaginal ... the past few weeks in two New Jersey litigations ... claims, the Firm announces. , A Case List ... the Bergen County proceeding established for products manufactured by ... few weeks earlier, when 90 fewer cases had been ...
(Date:3/1/2015)... 2015 ERISAPros is pleased ... Roddy to the professional staff of its Compliance Department. ... The Ohio State University-Mortiz College of Law. Prior to ... working with several Fortune 500 companies as well as ... corporate benefits. Her experiences range from benefit plan design, ...
(Date:3/1/2015)... Theme and plugin developers from Pixel Film ... for Final Cut Pro X entitled Transccordion. , “Transccordion ... FCPX editors project.” Said Christiana Austin, CEO of Pixel ... to easily drag and drop their accordion transition between ... controls over the parameters of this transition bundle and ...
(Date:2/28/2015)... The MCA Youth Empowerment Conference aims ... platform and gears towards the goal for a better ... group talks in smaller groups will be held after ... Development, Leadership, Entrepreneurship, Healthcare, Social and Volunteerism, Women and ... youths. , Young adults aged between 18-30 ...
Breaking Medicine News(10 mins):Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:ERISAPros Recruits Evelyn King, J.D. and Carolyn Roddy, J.D. to its Professional Staff 2Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4
... 2011 Horst Sievert, MD, PhD, a renowned ... O. Hartzler Master Clinical Operator Award in a ... Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the ... given each year to a physician who has ...
... Nov. 11 (HealthDay News) -- Age-related declines in physical ... a new study. "The more income and assets ... co-author Virginia Richardson, a professor of social work at ... The researchers analyzed data from roughly 6,500 participants ...
... -- ,Helping others can reduce cravings for alcohol and ... study suggests. Such cravings are major causes of ... noted. The study included 93 male and 102 ... courts for substance abuse treatment at a large facility ...
... a new oral cholera vaccine developed through the ... by the United Nations and based in Seoul, ... (WHO). Developed for use in developing countries ... to use in a single-dose vial and is ...
... using stem cells, in the hope to replace damaged ... for application in other degenerative conditions. Drs Clare ... Florey Neuroscience Institutes and the University of Melbourne. They ... collaboration being launched at the University of Melbourne today. ...
... Although it can be prevented with a vaccine, roughly 90 ... flu each year, resulting in about 1 million hospital admissions, ... online edition of The Lancet , the research also ... 111,500 children in 2008. According to the report, 99 percent ...
Cached Medicine News:Health News:Horst Sievert, M.D., Ph.D. presented with Master Clinical Operator Award at TCT 2011 2Health News:Helping Others Helps Teens Beat Substance Abuse 2Health News:IVI announces the prequalification of innovative cholera vaccine by the World Health Organization 2Health News:IVI announces the prequalification of innovative cholera vaccine by the World Health Organization 3Health News:Stem cell research hopes to repair brain damage of Parkinson's disease 2Health News:Stem cell research hopes to repair brain damage of Parkinson's disease 3
... powder Moisture: 10% Ash: ... gm/cm 2 Gel pH (1.5%): 5.0 7.0 ... 80 95C A (430 nm, 1.5%): ... >= 25,000 Ohms EEO (-m r ): ...
...
... Chamber has been used worldwide for two ... gas mixture and temperature. This airtight chamber ... in vitro fertilization, HIV isolation, creation of ... organ culture and the culturing of a ...
... A wide range of miniTHERM incubators is ... appropriate application solution for their specific requirements. ... liters, are compact and extremely space saving. ... microwave oven. It is possible to stack ...
Medicine Products: